Gislaine Kuminek

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Molecular Docking

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Gislaine Kuminek, Niloufar Salehi, Nicholas M Waltz, David C Sperry, Dale E Greenwood, Siddhi S Hate, Gregory E Amidon
Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study. Molecular pharmaceutics (2022)
Niloufar Salehi, Gislaine Kuminek, Jozef Al-Gousous, David C Sperry, Dale E Greenwood, Nicholas M Waltz, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis. Molecular pharmaceutics 18 (9) (2021)
Katie L Cavanagh, Gislaine Kuminek, Naír Rodríguez-Hornedo
Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior. Molecular pharmaceutics 17 (11) (2020)
Yaohui Huang, Gislaine Kuminek, Lilly Roy, Katie L Cavanagh, Qiuxiang Yin, Naír Rodríguez-Hornedo
Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation. Molecular pharmaceutics 16 (9) (2019)